ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2022$495,000
-89.7%
15,945
-80.3%
0.00%
-92.3%
Q4 2018$4,807,000
+33.3%
81,093
+48.0%
0.01%
+62.5%
Q3 2018$3,607,000
+162.7%
54,800
+101.5%
0.01%
+166.7%
Q2 2018$1,373,000
-54.0%
27,192
-52.1%
0.00%
-57.1%
Q1 2018$2,988,000
-64.6%
56,761
-80.4%
0.01%
-77.4%
Q1 2017$8,429,000290,2660.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders